Imported pain relievers that entered the Korean market late are not faring well in Korea's market.

This is because brand products like Tylenol, Geborin, and EZN have already settled in the market, and the fierce competition ongoing between multiple companies has left no room for late entrants.

As a result, Sanofi has withdrawn its license for ‘EVE Quick tablet’ on the 8th.

The 'EVE QUICK tablet' was first introduced to Korea in 2011 by Boehringer Ingelheim. Based on a non-steroidal anti-inflammatory pain killer, ibuprofen, its formula contains magnesium oxide and allyl isopropyl acetyl urea.

Like its name, the product was focused on treating pain e